![]() | |
Names | |
---|---|
IUPAC name
N-[5-[2-[(1,1-dimethyl-2-phenylethyl)amino]-1-hydroxyethyl]-2-hydroxyphenyl]methanesulfonamide
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.189.867 |
MeSH | Zinterol |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C19H26N2O4S | |
Molar mass | 378.49 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Zinterol is a beta-adrenergic agonist.[1]
Its structure is based on soterenol (antiarrhythmic) and phentermine.
References
[edit]- ^ Heubach JF, Graf EM, Molenaar P, et al. (May 2001). "Murine ventricular L-type Ca2+ current is enhanced by zinterol via β1-adrenoceptors, and is reduced in TG4 mice overexpressing the human β2-adrenoceptor". Br. J. Pharmacol. 133 (1): 73–82. doi:10.1038/sj.bjp.0704045. PMC 1572761. PMID 11325796.